|
|
 Previous Article | Table of Contents | Next Article 
Normal Platelets and Megakaryocytes Are Produced In Vivo in the Absence of Thrombopoietin
Stuart Bunting,
Ramon Widmer,
Terry Lipari,
Linda Rangell,
Hope Steinmetz,
Karen Carver-Moore,
Mark W. Moore,
Gilbert-Andre Keller, and
Frederic J. de Sauvage
From the Departments of Molecular Oncology, Pharmacokinetics and Metabolism, Molecular Biology, and Cardiovascular Research, Genentech Inc, South San Francisco, CA.
Thrombopoietin (TPO) has been established as the major regulator of megakaryocyte and platelet production. In vitro and in vivo studies have demonstrated that TPO affects both megakaryocyte proliferation and maturation. In vitro, TPO has been reported to be essential for full development of megakaryocytes and platelets. These studies are in contrast to results observed in vivo in mice deficient in the TPO or c-mpl gene (TPO-/- and c-mpl-/-). Both TPO-/- and c-mpl-/- mice exhibit a 90% reduction in megakaryocyte and platelet levels. But even with this small number of circulating platelets, these mice do not have any excessive bleeding. Ultrastructural analysis indicates that platelets and megakaryocytes present in the knockout mice are morphologically normal. Characterization of platelet function shows that platelets from knockout mice are functionally identical to the wild-type platelets as measured by upregulation of 125I-fibrinogen binding to platelets in response to adenosine diphosphate (ADP) stimulation and by platelet attachment to the immobilized extracellular matrix proteins, collagen and von Willebrand factor (vWF). These results demonstrate that in vivo, TPO is required for the control of megakaryocyte and platelet number but not for their maturation. Other factors with megakaryocytopoietic activity may be able to compensate for the maturational role of TPO and lead to the formation of normal megakaryocytes and platelets in TPO-/- and c-mpl-/- mice.
Blood, Vol. 90 No. 9 (November 1), 1997:
pp. 3423-3429
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
C. Leon, A. Eckly, B. Hechler, B. Aleil, M. Freund, C. Ravanat, M. Jourdain, C. Nonne, J. Weber, R. Tiedt, et al.
Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion
Blood,
November 1, 2007;
110(9):
3183 - 3191.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Junt, H. Schulze, Z. Chen, S. Massberg, T. Goerge, A. Krueger, D. D. Wagner, T. Graf, J. E. Italiano Jr., R. A. Shivdasani, et al.
Dynamic Visualization of Thrombopoiesis Within Bone Marrow
Science,
September 21, 2007;
317(5845):
1767 - 1770.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Wang, S. Cnhen, Y. Chen, H. Wang, H. Wu, H. Tang, W. Xiong, J. Ma, Y. Ge, Q. Lu, et al.
The role of Tyro 3 subfamily receptors in the regulation of hemostasis and megakaryocytopoiesis
Haematologica,
May 1, 2007;
92(5):
643 - 650.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Heo, U. Jariwala, J. Woo, Y. Zhan, K. A. Burke, L. Zhu, W. F. Anderson, and Y. Zhao
Involvement of Niemann-Pick Type C2 Protein in Hematopoiesis Regulation
Stem Cells,
June 1, 2006;
24(6):
1549 - 1555.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Pick, C. Perry, T. Lapidot, C. Guimaraes-Sternberg, E. Naparstek, V. Deutsch, and H. Soreq
Stress-induced cholinergic signaling promotes inflammation-associated thrombopoiesis
Blood,
April 15, 2006;
107(8):
3397 - 3406.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Sanchez, I. L. Weissman, M. Pallavicini, M. Valeri, P. Guglielmelli, A. M. Vannucchi, G. Migliaccio, and A. R. Migliaccio
Differential Amplification of Murine Bipotent Megakaryocytic/Erythroid Progenitor and Precursor Cells During Recovery from Acute and Chronic Erythroid Stress
Stem Cells,
February 1, 2006;
24(2):
337 - 348.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Amano, N. R. Hackett, S. Rafii, and R. G. Crystal
Thrombopoietin Gene Transfer-Mediated Enhancement of Angiogenic Responses to Acute Ischemia
Circ. Res.,
August 19, 2005;
97(4):
337 - 345.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. C. Hughan, Y. Senis, D. Best, A. Thomas, J. Frampton, P. Vyas, and S. P. Watson
Selective impairment of platelet activation to collagen in the absence of GATA1
Blood,
June 1, 2005;
105(11):
4369 - 4376.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Tong and H. F. Lodish
Lnk Inhibits Tpo-mpl Signaling and Tpo-mediated Megakaryocytopoiesis
J. Exp. Med.,
September 7, 2004;
200(5):
569 - 580.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Nagata, J. Yoshikawa, A. Hashimoto, M. Yamamoto, A. H. Payne, and K. Todokoro
Proplatelet formation of megakaryocytes is triggered by autocrine-synthesized estradiol
Genes & Dev.,
December 1, 2003;
17(23):
2864 - 2869.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Sitnicka, C. Brakebusch, I.-L. Martensson, M. Svensson, W. W. Agace, M. Sigvardsson, N. Buza-Vidas, D. Bryder, C. M.Cilio, H. Ahlenius, et al.
Complementary Signaling through flt3 and Interleukin-7 Receptor {alpha} Is Indispensable for Fetal and Adult B Cell Genesis
J. Exp. Med.,
November 17, 2003;
198(10):
1495 - 1506.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. S. Hitchcock, T. M. Skerry, M. R. Howard, and P. G. Genever
NMDA receptor-mediated regulation of human megakaryocytopoiesis
Blood,
August 15, 2003;
102(4):
1254 - 1259.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. C. Haznedaroglu, H. Goker, M. Turgut, Y. Buyukasik, and M. Benekli
Thrombopoietin as a Drug: Biologic Expectations, Clinical Realities, and Future Directions
Clinical and Applied Thrombosis/Hemostasis,
July 1, 2002;
8(3):
193 - 212.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C. Meunier, D. Bordereaux, F. Porteu, S. Gisselbrecht, S. Chretien, and G. Courtois
Cloning and Characterization of a Family of Proteins Associated with Mpl
J. Biol. Chem.,
March 8, 2002;
277(11):
9139 - 9147.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Battinelli, S. R. Willoughby, T. Foxall, C. R. Valeri, and J. Loscalzo
Induction of platelet formation from megakaryocytoid cells by nitric oxide
PNAS,
December 4, 2001;
98(25):
14458 - 14463.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Wang, R. Yu, and S. Melmed
Mice Lacking Pituitary Tumor Transforming Gene Show Testicular and Splenic Hypoplasia, Thymic Hyperplasia, Thrombocytopenia, Aberrant Cell Cycle Progression, and Premature Centromere Division
Mol. Endocrinol.,
November 1, 2001;
15(11):
1870 - 1879.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Levin, L. Cocault, C. Demerens, C. Challier, M. Pauchard, J. Caen, and M. Souyri
Thrombocytopenic c-mpl{-}/{-} mice can produce a normal level of platelets after administration of 5-fluorouracil: the effect of age on the response
Blood,
August 15, 2001;
98(4):
1019 - 1027.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ballmaier, M. Germeshausen, H. Schulze, K. Cherkaoui, S. Lang, A. Gaudig, S. Krukemeier, M. Eilers, G. Strau{beta}, and K. Welte
c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia
Blood,
January 1, 2001;
97(1):
139 - 146.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. J. Lane, S. Dias, K. Hattori, B. Heissig, M. Choy, S. Y. Rabbany, J. Wood, M. A. S. Moore, and S. Rafii
Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases
Blood,
December 15, 2000;
96(13):
4152 - 4159.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Vannucchi, F. Paoletti, S. Linari, C. Cellai, R. Caporale, P. R. Ferrini, M. Sanchez, G. Migliaccio, and A. R. Migliaccio
Identification and characterization of a bipotent (erythroid and megakaryocytic) cell precursor from the spleen of phenylhydrazine-treated mice
Blood,
April 15, 2000;
95(8):
2559 - 2568.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-M. Luoh, E. Stefanich, G. Solar, H. Steinmetz, T. Lipari, T. I. Pestina, C. W. Jackson, and F. J. de Sauvage
Role of the Distal Half of the c-Mpl Intracellular Domain in Control of Platelet Production by Thrombopoietin In Vivo
Mol. Cell. Biol.,
January 15, 2000;
20(2):
507 - 515.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
J. Levin, J.-P. Peng, G. R. Baker, J.-L. Villeval, P. Lecine, S. A. Burstein, and R. A. Shivdasani
Pathophysiology of Thrombocytopenia and Anemia in Mice Lacking Transcription Factor NF-E2
Blood,
November 1, 1999;
94(9):
3037 - 3047.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Vyas, K. Ault, C. W. Jackson, S. H. Orkin, and R. A. Shivdasani
Consequences of GATA-1 Deficiency in Megakaryocytes and Platelets
Blood,
May 1, 1999;
93(9):
2867 - 2875.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Sui, K. Tsuji, Y. Ebihara, R. Tanaka, K. Muraoka, M. Yoshida, K. Yamada, K. Yasukawa, T. Taga, T. Kishimoto, et al.
Soluble Interleukin-6 (IL-6) Receptor With IL-6 Stimulates Megakaryopoiesis From Human CD34+ Cells Through Glycoprotein (gp)130 Signaling
Blood,
April 15, 1999;
93(8):
2525 - 2532.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Hamada, R. Mohle, J. Hesselgesser, J. Hoxie, R. L. Nachman, M. A.S. Moore, and S. Rafii
Transendothelial Migration of Megakaryocytes in Response to Stromal Cell-derived Factor 1 (SDF-1) Enhances Platelet Formation
J. Exp. Med.,
August 3, 1998;
188(3):
539 - 548.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Williams, G. G. Pipia, N. S. Datta, and M. W. Long
Thrombopoietin Requires Additional Megakaryocyte-Active Cytokines for Optimal Ex Vivo Expansion of Megakaryocyte Precursor Cells
Blood,
June 1, 1998;
91(11):
4118 - 4126.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Murone, D. A. Carpenter, and F. J. de Sauvage
Hematopoietic Deficiencies in c-mpl and TPO Knockout Mice
Stem Cells,
January 1, 1998;
16(1):
1 - 6.
[Abstract]
[Full Text]
|
|
|
| |
